Memory Problems After 65? What Medicare Covers for Cognitive Assessment, Alzheimer’s Testing & Risk Reduction (2026)
“I'm repeating the same questions more often. Is this just normal aging?”
“I've started forgetting appointments and where I put things. Should I be tested for dementia?”
These are common concerns after age 65.
Occasional forgetfulness does not automatically mean Alzheimer’s disease.
Forgetting a name for a moment or occasionally misplacing your keys can happen with normal aging.
But repeatedly asking the same questions, getting lost in familiar places, struggling to manage money, or having increasing difficulty with tasks that used to be routine should not automatically be dismissed as:
“I'm just getting older.”
Memory problems can have many causes, and some are treatable.
For people with Medicare, there is a practical place to start.
Your Medicare Yearly Wellness Visit includes an assessment for signs of cognitive impairment, including dementia and Alzheimer’s disease. If concerns are found, Medicare Part B can also cover a separate, more detailed cognitive assessment.
Alzheimer’s diagnosis is also changing.
Doctors now have blood-based biomarker tests that did not exist a few years ago, and certain people with early Alzheimer’s disease may qualify for treatments designed to slow disease progression.
Insurance Dr.'s Quick Answer
Memory problems do not automatically mean Alzheimer’s disease. But if changes are becoming repetitive or noticeable, don't simply dismiss them as aging. Start with the cognitive assessment already included in your Medicare Yearly Wellness Visit, and move to more detailed testing only when appropriate.
There is still no guaranteed way to prevent Alzheimer’s disease.
But taking care of blood pressure, physical activity, sleep, hearing, diabetes, and social connection may support overall brain health and may help reduce dementia risk.
1. Are Alzheimer’s Disease and Dementia the Same Thing?
No.
Dementia is a general term for a decline in memory, judgment, reasoning, language, or other thinking abilities severe enough to interfere with daily life.
There are several causes of dementia.
Alzheimer’s disease is one of the most common.
In Alzheimer’s disease, changes involving proteins such as beta-amyloid and tau occur in the brain and may gradually affect memory and thinking.
But memory loss does not always mean Alzheimer’s disease.
Other possible causes can include:
- Medication side effects
- Depression or anxiety
- Sleep problems
- Thyroid or other medical conditions
- Vitamin B12 deficiency
- Infection or delirium
- Other neurological conditions
Some of these problems may improve when the underlying cause is treated.
That is why the first question should not always be:
“Do I have Alzheimer’s?”
A better starting question is:
“What could be causing this change in my memory or thinking?”
2. Start With Your Medicare Yearly Wellness Visit
Many people assume the Medicare Yearly Wellness Visit is the same thing as a routine annual physical.
It is not.
The Wellness Visit is designed to create or update a personalized prevention plan based on your health and risk factors.
As part of the visit, your provider performs a cognitive assessment looking for signs of dementia, including Alzheimer’s disease.
Your provider may look for changes such as:
- Difficulty remembering information
- Trouble learning new things
- Problems concentrating
- Difficulty managing finances
- Changes in everyday decision-making
Information from a spouse, adult child, friend, or caregiver can also be helpful.
How Much Does the Wellness Visit Cost?
If your provider accepts Medicare assignment and the visit meets Medicare requirements, you generally pay nothing for the Yearly Wellness Visit itself, and the Part B deductible does not apply.
However, additional tests or services performed during the same visit may result in separate costs.
3. What If the Doctor Finds a Cognitive Problem?
If your provider finds signs of cognitive impairment during the Wellness Visit—or during another medical appointment—Medicare Part B can cover a separate, more detailed cognitive assessment and care-planning visit.
That visit may include:
- Memory and decision-making assessment
- Medical history
- Medication review
- Evaluation for depression, anxiety, or delirium
- Review of daily functioning
- Discussion with a caregiver or family member
- Referrals to specialists
- Development of a care plan
You can also bring a spouse, family member, friend, or caregiver to help provide information.
What Does It Cost?
For a separate cognitive assessment visit, you generally pay 20% of the Medicare-approved amount after meeting the Part B deductible.
Medigap or other supplemental insurance may reduce your actual out-of-pocket cost.
4. When Is Forgetfulness More Than Normal Aging?
Everyone occasionally forgets a name or misplaces something.
That alone does not mean dementia.
But repeated or worsening changes deserve attention.
Examples include:
- Asking the same question repeatedly
- Frequently missing important appointments
- Forgetting medications
- Having new difficulty paying bills or managing money
- Getting confused or lost in familiar places
- Putting objects in unusual places and being unable to find them
- Struggling with tasks that used to be routine
- Becoming confused about time or place
- A spouse or adult child noticing changes before you do
That last point can be especially important.
Sometimes the person experiencing cognitive decline does not notice the change as clearly as someone close to them does.
5. Can Alzheimer’s Disease Now Be Detected With a Blood Test?
Blood testing can now help with diagnosis—but this needs to be understood carefully.
In May 2025, the FDA cleared through the 510(k) pathway the:
Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio
blood-based diagnostic test.
The test measures pTau217 and beta-amyloid 1-42 in plasma and calculates a ratio that can help predict whether amyloid plaques associated with Alzheimer’s disease are likely to be present in the brain.
That matters because amyloid confirmation has traditionally relied on tests such as:
- Amyloid PET scans
- Cerebrospinal fluid testing
A blood-based test may make part of the diagnostic process less invasive and more accessible.
But there is an important limitation.
The FDA-cleared Lumipulse test is intended for:
- Adults 55 and older
- People who already have signs or symptoms of cognitive decline
- Use as an aid in evaluating possible Alzheimer’s disease
It is not intended as a general screening test for healthy people without symptoms.
It is also not a stand-alone diagnostic test.
Results must be interpreted together with symptoms, medical history, cognitive evaluation, and other clinical information.
Important 2026 Update — Certain Lumipulse Lots Are Under Recall
As of October 2026, FDA records continue to list a Class II recall as Open and Classified for certain lots associated with the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio system.
The issue does not mean that all Lumipulse testing or all Alzheimer’s blood tests are invalid.
The recall involves specific affected lots.
FDA records indicate that affected products could produce a higher-than-expected number of positive or indeterminate classifications, including falsely elevated results.
If you recently had a Lumipulse test and received a positive or indeterminate result, it may be reasonable to ask the ordering provider or laboratory whether your result needs to be reviewed or confirmed.
FDA recall instructions advise affected laboratories to stop using the identified lots and review previously generated results with their medical director when appropriate.
6. Does FDA Clearance Mean Medicare Automatically Pays for the Blood Test?
No.
FDA clearance and Medicare coverage are two different questions.
The FDA decides whether a diagnostic device can be marketed for its intended use.
Medicare determines whether a particular service is covered under its own coverage and medical-necessity rules.
Coverage may depend on factors such as:
- The exact test ordered
- Medical necessity
- Why the test is being performed
- The laboratory
- Medicare billing rules
- Your individual coverage situation
So rather than requesting an Alzheimer’s blood test simply because the test exists, a better question for your doctor is:
“Do my memory changes warrant an Alzheimer’s evaluation, and would a blood biomarker test be useful in my case?”
Before having the test, ask the provider or laboratory about Medicare coverage and your expected out-of-pocket cost.
7. Why Does Early Diagnosis Matter More Today?
Because treatment options have changed.
For certain people with early Alzheimer’s disease, Medicare Part B can cover FDA-approved anti-amyloid monoclonal antibody treatments.
Examples include:
- Leqembi (lecanemab)
- Kisunla (donanemab)
Medicare identifies monoclonal antibodies for treating early Alzheimer’s disease as a type of drug that may be covered under Part B when coverage requirements are met.
Patients generally need:
- Mild cognitive impairment due to Alzheimer’s disease
or - Mild dementia due to Alzheimer’s disease
and confirmation that beta-amyloid plaques are present.
Additional imaging and monitoring may also be required.
The most important point is:
These treatments are not cures.
They do not restore memory that has already been lost or return a person to their previous condition.
For certain eligible patients with early Alzheimer’s disease, they are intended to slow or delay progression.
8. Can Alzheimer’s Disease Be Prevented?
This is where wording matters.
There is currently no proven way to guarantee that Alzheimer’s disease or dementia will never occur.
Age, genetics, medical conditions, environment, and lifestyle can all influence risk.
However, healthy lifestyle choices and management of cardiovascular and metabolic risk factors may support brain health.
Control High Blood Pressure
High blood pressure can damage blood vessels and is associated with poorer cardiovascular and brain health.
Managing blood pressure—especially beginning in midlife—is an important part of healthy aging.
Stay Physically Active
Walking and other regular physical activity support cardiovascular health and overall healthy aging.
The goal does not have to be extreme exercise.
Consistency matters.
Prioritize Sleep
Poor sleep can affect memory, mood, attention, and cognitive performance.
If you have severe snoring, repeated nighttime awakenings, or excessive daytime sleepiness, ask whether a sleep disorder such as sleep apnea should be evaluated.
Don't Ignore Hearing Loss
Hearing problems can contribute to difficulty communicating and social isolation.
If your hearing has noticeably declined, getting evaluated is more useful than simply assuming it is an unavoidable part of aging.
Manage Diabetes, Cholesterol, and Smoking
Conditions that affect the heart and blood vessels also matter for the brain.
A useful way to think about it is:
Many habits that are good for your heart are also good for your brain.
Stay Socially Connected
Spending time with family and friends, participating in community activities, learning new things, and staying engaged may support healthy aging.
9. Should I Start With a “Memory Supplement”?
That would usually not be my first step.
Before buying a product advertised for:
“memory improvement”
“brain health”
or
“dementia prevention”
it makes more sense to look for problems that may actually be identifiable and treatable.
For example:
- Medication side effects
- Blood pressure and diabetes
- Sleep problems
- Hearing loss
- Depression or anxiety
- Thyroid problems
- Vitamin B12 or other nutritional deficiencies
- Physical inactivity
Memory problems do not always mean Alzheimer’s disease.
That is why:
finding the cause is generally more useful than guessing at the cause.
10. What Should Medicare Beneficiaries Do Now?
If you are concerned about memory or cognitive health, start with practical steps.
✔ Schedule your Medicare Yearly Wellness Visit each year.
✔ Write down memory changes before the appointment.
✔ Ask family members whether they have noticed changes.
✔ Tell your provider about repeated questions, difficulty managing money, medication mistakes, or getting lost.
✔ Ask whether a separate Cognitive Assessment is appropriate.
✔ Do not assume an Alzheimer’s blood test is a routine screening test.
✔ Ask about Medicare coverage before undergoing newer diagnostic testing.
✔ Keep blood pressure, diabetes, and cholesterol under control.
✔ Stay physically active.
✔ Address hearing problems.
✔ Prioritize sleep.
✔ Stay socially connected.
The goal is to avoid two extremes:
being so afraid of dementia that you avoid evaluation
and
assuming every small memory lapse means Alzheimer’s disease.
Insurance Dr.'s Take
The main message of this article is not:
“Everyone over 65 needs more Alzheimer’s testing.”
It is much simpler.
Don't ignore meaningful changes, and start with the preventive benefits Medicare already gives you.
Begin with the Yearly Wellness Visit.
If something looks concerning, move to a more detailed cognitive assessment.
If medically appropriate, the next steps may include blood biomarker testing, imaging, laboratory testing, or specialist evaluation.
At the same time, pay attention to the things you can influence now.
Manage your blood pressure.
Keep moving.
Sleep well.
Address hearing problems.
Control diabetes and cholesterol.
Stay connected to other people.
Alzheimer’s disease remains a difficult illness, and there is still no cure.
But compared with only a few years ago, doctors now have better tools for evaluating cognitive changes earlier and more treatment options for certain people with early Alzheimer’s disease.
So if you have noticed a change in your memory, you do not necessarily need to begin with the newest or most complicated test.
At your next Medicare Wellness Visit, one simple question may be enough to start:
“My memory doesn't seem quite the same as before. Can we check my cognitive health too?”
I think that is one of the most practical places to begin.
Key Takeaways
Memory loss does not automatically mean Alzheimer’s disease.
A Medicare Yearly Wellness Visit includes an assessment for signs of cognitive impairment.
If problems are suspected, Medicare Part B can cover a separate, more detailed Cognitive Assessment.
Blood-based Alzheimer’s testing now exists, but the FDA-cleared Lumipulse test is not intended as routine screening for people without symptoms and is not a stand-alone diagnosis.
Certain people with early Alzheimer’s disease may qualify for treatments designed to slow progression, but these treatments do not cure Alzheimer’s or restore lost memory.
And perhaps the most practical thing you can do today is:
Don't ignore meaningful changes—and take care of the health factors you can still influence.
Official Sources & References
Medicare — Yearly “Wellness” Visits
Official Medicare information on the Yearly Wellness Visit, including the cognitive assessment used to look for signs of dementia and Alzheimer’s disease, eligibility, and cost-sharing rules.
Medicare — Yearly Wellness Visits
Medicare — Cognitive Assessment & Care Plan Services
Official Medicare coverage information for a separate, more detailed cognitive assessment and care-planning visit when cognitive impairment is suspected.
Medicare — Cognitive Assessment & Care Plan Services
FDA — First Blood Test Used in Diagnosing Alzheimer’s Disease
Official FDA information on the 2025 clearance of the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, including its intended use for adults age 55 and older with signs or symptoms of cognitive decline. FDA — Alzheimer’s Blood Test
FDA — Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio Class II Recall
Official FDA recall record for affected Lumipulse lots. As of the latest FDA record, the recall remains Open and Classified, and the concern involves falsely elevated positive or indeterminate results in affected products. FDA — Lumipulse Class II Recall
Medicare — Monoclonal Antibodies for Treating Early Alzheimer’s Disease
Official Medicare information on Part B coverage for FDA-approved anti-amyloid treatments such as Leqembi (lecanemab) and Kisunla (donanemab), including eligibility and cost-sharing requirements.
Medicare — Early Alzheimer’s Treatments
National Institute on Aging — Memory Problems, Forgetfulness, and Aging
Official NIA guidance on normal age-related forgetfulness, signs that may suggest a more serious cognitive problem, and other potentially treatable causes of memory loss.
NIA — Memory Problems, Forgetfulness, and Aging
National Institute on Aging — Cognitive Health and Older Adults
Official NIA information on blood pressure, physical activity, diabetes, cholesterol, medications, diet, and other factors related to maintaining cognitive health as people age. NIA — Cognitive Health and Older Adults
Disclaimer
This article is for general educational purposes only and does not provide individualized medical advice, diagnosis, or treatment recommendations.
If you or a family member is experiencing memory loss or cognitive changes, speak with a qualified health care professional.
Medicare coverage and out-of-pocket costs may vary depending on the test, provider, facility, treatment, Medicare Advantage plan, Medigap coverage, and other insurance.
Last Updated: October 2026
댓글
댓글 쓰기